By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Kyorin Pharmaceutical Co., Ltd. 

5, Kanda Surugadai 2-chome
Tokyo    101  Japan
Phone: Fax:




Company News
SkyePharma Inc. (SKYE)’s Partner Kyorin Pharmaceutical Co., Ltd. Launches 120-Puff Version Of Flutiform In Japan 12/1/2014 2:35:16 PM
Eisai Company, Ltd. (ESALY.PK) And Kyorin Pharmaceutical Co., Ltd. Enter Into Agreement Concerning Compound Library Use For The Development Of New Antibacterial Agents 9/19/2014 7:32:52 AM
Kyorin Pharmaceutical Co., Ltd. and BioLeap Enter Research Collaboration 1/9/2012 6:30:16 AM
Kyorin Pharmaceutical Co., Ltd. and Eisai Company, Ltd. (ESALY.PK) Sign License Agreement for Development and Marketing of Uritos(R) Tablets in China, India, Sri Lanka and ASEAN Countries 9/29/2009 10:31:59 AM
Skyepharma PLC (SKYE) Announces Exclusive License Agreement with Kyorin Pharmaceutical Co., Ltd. for Development and Distribution of Flutiform(TM) in Japan 4/22/2008 10:20:58 AM
Bristol-Myers Squibb Company (BMY) To Stop Sale, Manufacture Of Antibiotic Tequin 5/2/2006 11:15:39 AM
Kyorin Pharmaceutical Co., Ltd. To Reorganize Its Group Businesses In October 4/21/2006 10:33:53 AM
ActivX Biosciences, Inc./Kyorin Pharmaceutical Co., Ltd. Begins First U.S. Phase I Study For Novel Anti-Diabetic Drug 3/15/2006 10:19:54 AM
Kyorin Pharmaceutical Co., Ltd. Licenses Immunosuppressant Drug To Novartis Corporation (NVS) 2/16/2006 10:23:43 AM
Dainippon Pharmaceutical And Kyorin Pharmaceutical Co., Ltd. To Collaborate In Development Of Drug Candidate For Diabetic Complication10/19/2005 5:13:06 PM